2025 HCPCS Code J1840
Injection, kanamycin sulfate, up to 500 mg
TAGS: kanamycin| Notice | HCPCS J1840 terminated on March 31, 2024. |
| Short Description | Kanamycin sulfate 500 mg inj |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | January 01, 1982 |
| HCPCS Action Effective Date | April 01, 2024 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J8612 - Oral methotrexate (xatmep)
- J8650 - Nabilone oral
- J8655 - Oral netupitant, palonosetro
- J8670 - Rolapitant, oral, 1mg
- J8700 - Temozolomide
- J8705 - Topotecan oral
- J8999 - Oral prescription drug chemo
- J9000 - Doxorubicin hcl injection
- J9010 - Alemtuzumab injection
- J9015 - Aldesleukin injection
- J9017 - Arsenic trioxide injection
- J9019 - Erwinaze injection
- J9020 - Asparaginase, nos
- J9021 - Inj, aspara, rylaze, 0.1 mg
- J9022 - Inj, atezolizumab,10 mg
- J9023 - Injection, avelumab, 10 mg
- J9025 - Azacitidine injection
- J9027 - Clofarabine injection
- J9029 - Instill adstiladrin, tx dose
- J9030 - Bcg live intravesical 1mg